Structure of the doublet bands in doubly odd nuclei: The case of 128Cs^{128}Cs

The structure of the $\Delta J = 1$ doublet bands in $^{128}Cs$ is investigated within the framework of the Interacting Vector Boson Fermion Model (IVBFM). A new, purely collective interpretation of these bands is given on the basis of the used boson-fermion dynamical symmetry of the model. The energy levels of the doublet bands as well as the absolute $B(E2)$ and $B(M1)$ transition probabilities between the states of both yrast and yrare bands are described quite well. The observed odd-even staggering of both $B(M1)$ and $B(E2)$ values is reproduced by the introduction of an appropriate interaction term of quadrupole type, which produces such a staggering effect in the transition strengths. The calculations show that the appearance of doublet bands in certain odd-odd nuclei could be a consequence of the realization of a larger dynamical symmetry based on the non-compact supersymmetry group $OSp(2\Omega /12, R)$.Comment: 12 pages, 8 figure

New Description of the Doublet Bands in Doubly Odd Nuclei

The experimentally observed $\Delta I = 1$ doublet bands in some odd-odd nuclei are analyzed within the orthosymplectic extension of the Interacting Vector Boson Model (IVBM). A new, purely collective interpretation of these bands is given on the basis of the obtained boson-fermion dynamical symmetry of the model. It is illustrated by its application to three odd-odd nuclei from the $A\sim 130$ region, namely $^{126}Pr$, $^{134}Pr$ and $^{132}La$. The theoretical predictions for the energy levels of the doublet bands as well as $E2$ and $M1$ transition probabilities between the states of the yrast band in the last two nuclei are compared with experiment and the results of other theoretical approaches. The obtained results reveal the applicability of the orthosymplectic extension of the IVBM.Comment: 15 pages, 13 figure

Metals and kidney markers in adult offspring of endemic nephropathy patients and controls: a two-year follow-up study

Abstract Background The etiology of Balkan Endemic Nephropathy, (BEN), a tubulointerstitial kidney disease, is unknown. Although this disease is endemic in rural areas of Bosnia, Bulgaria, Croatia, Romania, and Serbia, similar manifestations are reported to occur in other regions, for instance Tunisia and Sri Lanka. A number of explanations have been stated including lignites, aristolochic acid, ochratoxin A, metals, and metalloids. Etiologic claims are often based on one or a few studies without sound scientific evidence. In this systematic study, we tested whether exposures to metals (cadmium and lead) and metalloids (arsenic and selenium) are related to Balkan Endemic Nephropathy. Methods In 2003/04 we recruited 102 adults whose parents had BEN and who resided in one of three communities (Vratza, Bistretz, or Beli Izvor, Bulgaria). A control group comprised of 99 adults having non-BEN hospitalized parents was enrolled in the study during the same time. We conducted face-to-face interviews, ultrasound kidney measurements, and determined kidney function in two consecutive investigations (2003/04 and 2004/05). Metals and metalloids were measured in urine and blood samples. To assess the agreement between these consecutive measurements, we calculated intraclass correlation coefficients. Repeated measurement data were analyzed using mixed models. Results We found that cadmium and arsenic were associated with neither kidney size nor function. Lead had a significant but negligible effect on creatinine clearance. Selenium showed a weak but significant negative association with two of the four kidney parameters, namely creatinine clearance and β2-microglobulin. It was positively related to kidney length. These associations were not restricted to the offspring of BEN patients. Adding credence to these findings are reports showing comparable kidney effects in animals exposed to selenium. Conclusion The findings of this 2-year follow-up study indicate that metals and metalloids do not play a role in the etiology of Balkan Endemic Nephropathy. Against the assumption in the literature, selenium was not protective but a risk factor. Since comparable associations were observed in animals, future studies are needed to explore whether selenium may have adverse renal effects in humans.</p

Data augmentation in Bayesian neural networks and the cold posterior effect

Data augmentation is a highly effective approach for improving performance in deep neural networks. The standard view is that it creates an enlarged dataset by adding synthetic data, which raises a problem when combining it with Bayesian inference: how much data are we really conditioning on? This question is particularly relevant to recent observations linking data augmentation to the cold posterior effect. We investigate various principled ways of finding a log-likelihood for augmented datasets. Our approach prescribes augmenting the same underlying image multiple times, both at test and train-time, and averaging either the logits or the predictive probabilities. Empirically, we observe the best performance with averaging probabilities. While there are interactions with the cold posterior effect, neither averaging logits or averaging probabilities eliminates it

Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements

BACKGROUND AND OBJECTIVE: Acenocoumarol (AC) is a coumarin derivative, vitamin K antagonist anticoagulant drug. It has a narrow therapeutic index and shows large pharmacokinetic and pharmacodynamic interindividual variability. Our objective was to investigate the association between AC dose requirements to achieve a target level of anticoagulation and genetic polymorphisms of genes possibly associated with its metabolism (CYP1A2, CYP2C9, CYP2C19, CYP3A4, CYP3A5) and transport (ABCB1). METHODS: Ninety-six Bulgarian patients treated orally with AC for at least 3 months were included. They were separated into three groups according to their AC dose requirement, i.e. low, medium and high. RESULTS AND DISCUSSION: CYP2C9*1/*3 (associated with an intermediate CYP2C9 activity), CYP2C9*2/*2, and CYP2C9*2/*3 genotypes (associated with a low CYP2C9 activity) were more prevalent in the group with low dose requirement of AC compared with the other two groups (P = 0.003). The frequency of CYP2C9*1/*1 genotype, which is associated with an extensive CYP2C9 activity, was higher in the group of patients with high dose requirements (79%), compared with the groups of the medium and low dose requirements (67% and 21% respectively). In addition, the ABCB1 2677GG/3435CC haplotype was associated with use of lower AC dose, whereas the 2677TT/3435TT and 2677GT/3435TT haplotypes were associated with use of higher AC dose (P = 0.03). The distribution of polymorphisms of other genes did not show significant differences between the three groups. CONCLUSION: In vivo, cytochromes P450 isoforms other than CYP2C9, and the permeability glycoprotein transporter, which is encoded by the ABCB1 gene, were not significantly associated with dose requirement of AC. In our Bulgarian patients, the presence of CYP2C9*2 or/and CYP2C9*3 alleles, as well as the ABCB1 2677GG/3435CC haplotype were associated with low dose requirement of AC